<DOC>
	<DOCNO>NCT00090207</DOCNO>
	<brief_summary>A multicenter trial ass safety efficacy investigational drug prevention chemotherapy-induced nausea vomiting ( CINV ) patient confirm solid tumor treat chemotherapy regimen include cisplatin . The study evaluate investigational drug treatment CINV first cycle treatment cisplatin .</brief_summary>
	<brief_title>Aprepitant Prevention Chemotherapy Induced Nausea Vomiting ( CINV ) Associated With Highly Emetogenic Chemotherapy ( 0869-801 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Patient great 18 year age . Patient schedule receive his/her first course cisplatin chemotherapy solid tumor . Patient prognosis ( life expectancy ) great equal 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>